Dara Aisner, MD, PhD
Dr. Dara Aisner is a board-certified certified Anatomic and Molecular Genetic Pathologist. She is a Professor of Pathology at the University of Colorado School of Medicine in Denver, Colorado and a member of the University of Colorado Comprehensive Cancer Center. She is also board certified in Clinical Informatics.
She is the Director of the Colorado Molecular Correlates Laboratory and the Vice Chair for Genomic Laboratory Medicine within the Department of Pathology. The laboratory provides CLIA level clinical services in the evaluation of patient tumor specimens for personalized medicine approaches.
She is a member of numerous oncology pathology and guidelines committees including the NCCN Non-Small Cell Lung Cancer panel, among others. Dr. Aisner is a leader in helping establish formal processes helping medical oncologists and pathologists work optimally together, which is especially important in today’s world of precision diagnostics, personalized medicine and next-generation sequencing testing.
Financial relationships
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:AstraZenecaTopic:Advisory BoardDate added:01/04/2023Date updated:01/04/2023
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:Sanofi GenzymeTopic:Advisory BoardDate added:01/04/2023Date updated:01/04/2023
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:Loxo/Eli LillyTopic:Advisory BoardDate added:01/04/2023Date updated:01/04/2023
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:GenentechTopic:Advisory BoardDate added:01/04/2023Date updated:01/04/2023
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:AbbvieTopic:Advisory BoardDate added:01/04/2023Date updated:01/04/2023
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:TakedaTopic:Advisory BoardDate added:01/04/2023Date updated:01/04/2023